Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evidence-based prioritisation and enrichment of genes interacting with metformin in type 2 diabetes.

Diabetologia - 1 Nov 2017

Dawed Adem Y, Ali Ashfaq, Zhou Kaixin, Pearson Ewan R, Franks Paul W

Abstract excerpt

AIMS/HYPOTHESIS: There is an extensive body of literature suggesting the involvement of multiple loci in regulating the action of metformin; most findings lack replication, without which distinguishing true-positive from false-positive findings is difficult. To address this, we undertook evidence-based, multiple data integration to determine the validity of published evidence. METHODS: We (1) built a database of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Algorithms
Share to Blood Glucose
Share to Diabetes Mellitus, Type 2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genome-Wide Association Study

Share to Genotype

Share to Glucose Transporter Type 4

Share to Metformin

Share to Polymorphism, Single Nucleotide

Source

Open in PubMed Open full text

Identifiers

PMID: 28842730
DOI: 10.1007/s00125-017-4404-2
PMCID: PMC6448905

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evidence-based prioritisation and enrichment of genes interacting with metformin in type 2 diabetes.PMID 28842730Read ↗

Pathways targeted by antidiabetes drugs are enriched for multiple genes associated with type 2 diabetes risk.Semantic proximity Read ↗

Leveraging Genetic Correlations to Prioritize Drug Groups for Repurposing in Type 2 DiabetesSemantic proximity Read ↗

Multi-Omics Analysis Revealed the rSNPs Potentially Involved in T2DM Pathogenic Mechanism and Metformin Response.Semantic proximity Read ↗

Prioritization of therapeutic targets for dyslipidemia using integrative multi-omics and multi-trait analysis.Semantic proximity Read ↗

Implications of genetic variations, differential gene expression, and allele-specific expression on metformin response in drug-naïve type 2 diabetes.Semantic proximity Read ↗

Integrated Bioinformatics and Pharmacogenomic Profiling of a Gene Panel in Diabetes Mellitus Treatment ResponseSemantic proximity Read ↗

Common variants in 40 genes assessed for diabetes incidence and response to metformin and lifestyle intervention in the diabetes prevention program.Semantic proximity Read ↗

Prioritization of genes associated with type 2 diabetes mellitus for functional studies.Semantic proximity Read ↗

Integration of genetic evidence to identify approved drug targetsSemantic proximity Read ↗

An Update on the Pharmacogenomics of Metformin: Progress, Problems and PotentialSemantic proximity Read ↗

Multi-layered genetic approaches to identify approved drug targetsSemantic proximity Read ↗

Using EHR-Linked Biobank Data to Study Metformin Pharmacogenomics.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.